Metformin HCl

貨號 Cat. No.
S1950
規格 Size
10mM/1mL、50mg
品牌 Brand
Selleckchem

Description

 



Metformin HCl
Catalog No.S19502 Product Citations

Metformin decreases hyperglycemia primarily by suppressing glucose production by the liver (hepatic gluconeogenesis).


















Size Price Stock Quantity  
















10mM/1mLIn DMSO USD 158 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
50mg USD 122 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 




Distributor Tel: +886-2-2827-1197jimmy@new.abscience.com.tw


Biological Activity







































Description Metformin decreases hyperglycemia primarily by suppressing glucose production by the liver (hepatic gluconeogenesis).
Targets            
IC50            
In vitro Metformin (500 μM) activates AMPK in hepatocytes, as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidation is induced, and expression of lipogenic enzymes is suppressed. Metformin (2 mM) activates muscle AMPK and promotes glucose uptake. Metformin (500 nM) or AICAR strongly suppresses SREBP-1 mRNA expression in rat hepatocytes. Metformin ameliorates hyperglycemia without stimulating insulin secretion, promoting weight gain, or causing hypoglycemia. Metformin has beneficial effects on circulating lipids linked to increased cardiovascular risk. Metformin decreases hepatic glucose production and increases skeletal myocyte glucose uptake. [1] Metformin requires LKB1 in the liver to lower blood glucose levels. [2]Metformin (2 mM) leads to a significant increase in the activity of both α1- and α2-containing complexes in muscle cells. Metformin (2 mM) also increases threonine 172 phosphorylation in muscle cells. [3]
In vivo Metformin (100 mg/ml, po) treatment produces significant decreases in hepatic expression of mRNAs for SREBP-1, FAS, and S14 in SD rats that are consistent with effects documented in cells. Metformin also decreases hepatic lipids in obese mice. [1] Metformin (250 mg/kg, i.p.) increases AMPK phosphorylation in livers of wild-type mice. Metformin (250 mg/kg, i.p.) treatment reduces blood glucose by more than 50% in the wild-type mice on a high-fat diet. Metformin (250 mg/kg, i.p.) treatment also loweres blood glucose in the ob/ob mice by 40%. [2]
Features  

Protocol(Only for Reference)


1


References


Chemical Information


Download Metformin HCl SDF


 

















Molecular Weight (MW) 165.62
Formula

C4H11N5.HCl


CAS No. 1115-70-4















Storage 3 years -20℃Powder
6 months-80℃in DMSO
Syonnyms Glucophage, Riomet, Diabex

 


























Solubility (25°C) * In vitro DMSO <1 mg/mL (<1 mM)
Water 33 mg/mL (199 mM)
Ethanol <1 mg/mL (<1 mM)
In vivo Saline, 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.


 








Chemical Name  

 


Product Citations (2)




 


 


 

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢